Cart

This article PDF is available for purchase only. PDFs are free for members! Become a member and save today

Remove item Thumbnail image Product Price Quantity Subtotal
× Placeholder Efficacy and Safety of Duloxetine 60 mg Once Daily in the Treatment of Pain in Patients With Major Depressive Disorder and At Least Moderate Pain of Unknown Etiology: A Randomized Controlled Trial PDF $40.00
$40.00
× Placeholder Impact of Childhood Life Events and Childhood Trauma on the Onset and Recurrence of Depressive and Anxiety Disorders PDF $40.00
$40.00
× Placeholder Differences in Duloxetine Dosing Strategies in Smoking and Nonsmoking Patients: Therapeutic Drug Monitoring Uncovers the Impact on Drug Metabolism PDF $40.00
$40.00
× Placeholder Impact of Depression on Anxiety, Well-being, and Suicidality in Mexican Adolescent and Young Adult Students From Mexico City: A Mental Health Screening Using Smartphones PDF $40.00
$40.00
× Placeholder Three-Year Incidence and Predictors of First-Onset of DSM-IV Mood, Anxiety, and Substance Use Disorders in Older Adults: Results From Wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions [CME] PDF $40.00
$40.00
× Placeholder Meta-Analysis of Efficacy and Treatment-Emergent Suicidality in Adults by Psychiatric Indication and Age Subgroup Following Initiation of Paroxetine Therapy: A Complete Set of Randomized Placebo-Controlled Trials PDF $40.00
$40.00
× Placeholder Impact of Comorbid Attention Deficit Disorder on the Direct Medical Costs of Treating Adults With Depression in Managed Care PDF $40.00
$40.00
× Placeholder The Art of Sharing the Diagnosis and Management of Alzheimer's Disease With Patients and Caregivers: Recommendations of an Expert Consensus Panel PDF $40.00
$40.00
× Placeholder Prediction of Late-Onset Psychiatric Disorder in Survivors of Severe Injury: Findings of a Latent Transition Analysis PDF $40.00
$40.00
× Placeholder Health-Related Quality of Life Across the Anxiety Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF $40.00
$40.00
× Placeholder The Relative Contribution of Cognition and Symptomatic Remission to Functional Outcome Following Treatment of a First Episode of Psychosis PDF $40.00
$40.00
× Placeholder Serum Folate, Vitamin B12, and Homocysteine in Major Depressive Disorder, Part 2: Predictors of Relapse During the Continuation Phase of Pharmacotherapy PDF $40.00
$40.00
× Placeholder Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016 PDF $40.00
$40.00
× Placeholder Effect of Comorbid Depression on Outcomes in Diabetes and Its Relationship to Quality of Care and Patient Adherence: A Statewide Primary Care Ambulatory Research and Resources Consortium Study PDF $40.00
$40.00
× Placeholder A Survey on the Impact of Being Depressed on the Professional Status and Mental Health Care of Physicians PDF $40.00
$40.00
× Placeholder A Double-Blind Placebo-Controlled Study of the Efficacy and Safety of Paroxetine in the Treatment of Pathological Gambling PDF $40.00
$40.00
× Placeholder Neuropsychiatric Manifestation of Tick-Borne Disease and the Importance of Screening in Endemic Regions PDF $40.00
$40.00
× Placeholder Recursive Subsetting to Identify Patients in the STAR*D: A Method to Enhance the Accuracy of Early Prediction of Treatment Outcome and to Inform Personalized Care PDF $40.00
$40.00
× Placeholder The Safety of Olanzapine in Adolescents With Schizophrenia or Bipolar I Disorder: A Pooled Analysis of 4 Clinical Trials PDF $40.00
$40.00
× Placeholder Elevated Hemoglobin A1c as a Possible Indicator of Diabetes Mellitus and Diabetic Ketoacidosis in Schizophrenia Patients Receiving Atypical Antipsychotics PDF $40.00
$40.00
× Placeholder Early Nonresponse in the Antipsychotic Treatment of Acute Mania: A Criterion for Reconsidering Treatment? Results From an Individual Patient Data Meta-Analysis PDF $40.00
$40.00
× Placeholder The Role of Consultation-Liaison Psychiatry in the COVID-19 Pandemic PDF $40.00
$40.00
× Placeholder National Trends in and Correlates of Nonmedical Use of Prescription Stimulants, Nonmedical Use Frequency, and Use Disorders PDF $40.00
$40.00
× Placeholder Are Overweight, Obesity, and Extreme Obesity Associated With Psychopathology? Results From the National Epidemiologic Survey on Alcohol and Related Conditions. PDF $40.00
$40.00
× Placeholder Review of Maintenance Trials for Major Depressive Disorder: A 25-Year Perspective From the US Food and Drug Administration PDF $40.00
$40.00
× Placeholder Prevalence and Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia in a Geriatric Psychiatry Unit: A Retrospective Analysis PDF $40.00
$40.00
× Placeholder How the Probability and Potential Clinical Significance of Pharmacokinetically Mediated Drug-Drug Interactions Are Assessed in Drug Development: Desvenlafaxine as an Example PDF $40.00
$40.00
× Placeholder A National Study of the Association of Attachment Styles With Depression, Social Anxiety, and Suicidal Ideation Among Lebanese Adolescents PDF $40.00
$40.00
× Placeholder Serum Prolactin Levels Among Outpatients With Major Depressive Disorder During the Acute Phase of Treatment With Fluoxetine PDF $40.00
$40.00
× Placeholder Patient Compliance to a New Enteric-Coated Weekly Formulation of Fluoxetine During Continuation Treatment of Major Depressive Disorder PDF $40.00
$40.00
× Placeholder Reduced Suicidal Ideation in Bipolar I Disorder Mixed-Episode Patients in a Placebo-Controlled Trial of Olanzapine Combined With Lithium or Divalproex. PDF $40.00
$40.00
× Placeholder Decreased Nocturnal Oxytocin Levels in Anorexia Nervosa Are Associated With Low Bone Mineral Density and Fat Mass PDF $40.00
$40.00
× Placeholder Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan PDF $40.00
$40.00
× Placeholder Complementary and Alternative Medicine for Major Depressive Disorder: A Meta-Analysis of Patient Characteristics, Placebo-Response Rates, and Treatment Outcomes Relative to Standard Antidepressants PDF $40.00
$40.00

Instead of purchasing individual articles, subscribe to our membership plan and get unlimited access to all article PDFs from both of our journals.


Join Now

Cart totals

Subtotal $1,360.00
Total $1,360.00
Proceed to checkout

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe